CSChristopher W. Smith
Christopher W. Smith
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher W. Smith has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Stephen P. Watson
University of Birmingham
3 shared publications - Mark R. Thomas
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences University of Birmingham Birmingham UK
2 shared publications - Natalie S. Poulter
University of Birmingham
2 shared publications - Phillip Lindsay Ross Nicolson
Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
2 shared publications - Samantha J. Montague
University of Birmingham
2 shared publications - Alexandre Slater
University of Birmingham
1 shared publication
Latest Publications
- Open Access
- 14 October 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (12) , 2939-2952
The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
- 14 October 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (12) , 2939-2952
Open AccessThe Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity
- Open Access
- 27 July 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (11) , 2617-2631
Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
- 27 July 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (11) , 2617-2631
Open AccessAnti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
- Open Access
- 4 May 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (3) , e12707
Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months
- 4 May 2022
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (3) , e12707
Open AccessAnti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months